Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    507 - The PAAB does not allow the use of post-hoc study analyses to support claims. Are there any exceptions to this? For example if the post-hoc analysis was done for safety reasons at the request of the FDA, would that publication be permitted to support claims?

    Claims & Support/References for Claims
    1
    1
    99
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • Jennifer Carroll
      Jennifer Carroll last edited by

      Post hoc analysis is not accepted as evidentiary support for claims of benefit (PAAB s 3.1.1). The only exception which readily comes to mind is if the data is in the Health Canada approved Terms of Market Authorization.

      1 Reply Last reply Reply Quote 0
      • First post
        Last post